Eli Lilly and Company (Lilly) has secured approval from the U.S. Food and Drug Administration (FDA) for its new biologic treatment, EBGLYSS (lebrikizumab-lbkz), for moderate-to-severe atopic dermatitis in adults and children aged 12 and older. This biologic drug is positioned as a first-line treatment option, promising substantial relief for patients whose eczema is not well […]
Galderma has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) approving Nemluvio (nemolizumab) for the treatment of prurigo nodularis in adults. This approval allows Nemluvio to be administered as a pre-filled pen for subcutaneous injection, providing a new option for patients suffering from this challenging condition. The drug’s approval follows its […]
Galderma, renowned for its leadership in dermatology, and L’Oréal, a giant in beauty and skincare, have unveiled a groundbreaking partnership marked by L’Oréal acquiring a 10% stake in Galderma. This alliance is poised to reshape the dermatological landscape, combining Galderma’s scientific prowess in skin health with L’Oréal’s expertise in beauty innovations. Unleashing Innovation in Dermatology […]
SkinBioTherapeutics plc (AIM: SBTX), a leading life science company focused on skin health, has announced a strategic partnership with the Umesh Modi Group, a renowned Indian conglomerate, to launch its Dermatonics product line, including Pheet and Dermatonics Once Heel Balm, in the Asia, Middle East, and Africa (AMEA) regions. This collaboration, following a manufacturing and […]
Clinique, a leading skincare brand, and the Icahn School of Medicine at Mount Sinai have announced a groundbreaking philanthropic partnership to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center. This collaboration marks a significant advancement in dermatology research, focusing on the biological mechanisms of skin aging, skin allergies, and inflammatory conditions such as eczema (atopic […]
Aarti Drugs Limited (NSE: AARTIDRUGS; BSE:524348), a Mumbai-based pharmaceutical powerhouse, has officially announced the start of its dermatology product production at its newly established facility in Tarapur, Maharashtra. As of January 30, 2024, the company has begun manufacturing an array of dermatology products, marking a significant step in its expansion strategy. The new facility in […]
Arcutis Biotherapeutics, Inc., a pioneer in immuno-dermatology, has announced the U.S. Food and Drug Administration’s (FDA) approval of their new drug application for ZORYVE (roflumilast) topical foam, 0.3%, aimed at treating seborrheic dermatitis in individuals aged 9 years and older. This approval marks a significant advancement in dermatological care, with ZORYVE being the first drug […]
Supriya Lifescience, a front-runner in speciality active pharmaceutical ingredients (API) and CDMO services in India, has penned an agreement with Kalinga Institute of Technology for the advancement of GelHeal, an innovative protein-based hydrogel aimed at skin regeneration and wound healing. This collaboration highlights the company’s commitment to addressing complex healthcare challenges by creating cost-effective and […]
Novartis, a global leader in immuno-dermatology and rheumatology, announced the U.S. Food and Drug Administration’s approval of Cosentyx (secukinumab) for treating adults with moderate to severe hidradenitis suppurativa (HS). This approval places Cosentyx as the only FDA-approved fully human biologic that targets interleukin-17A (IL-17A), a key cytokine involved in HS inflammation. Understanding Hidradenitis Suppurativa and […]
LEO Pharma A/S said that the European Medicines Agency (EMA) has validated its marketing authorization application (MAA) for delgocitinib cream. Touted as a groundbreaking topical pan-Janus kinase (JAK) inhibitor, this cream is specifically designed for adult patients battling moderate to severe chronic hand eczema (CHE). This validation kicks off the official review process by the […]